Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Net Cash Flow: 2009-2025

Historic Net Cash Flow for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to -$1.5 million.

  • BIO-TECHNE's Net Cash Flow fell 152.28% to -$16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.2 million, marking a year-over-year decrease of 275.83%. This contributed to the annual value of -$1.5 million for FY2025, which is 94.21% up from last year.
  • Latest data reveals that BIO-TECHNE reported Net Cash Flow of -$1.5 million as of FY2025, which was up 94.21% from -$26.4 million recorded in FY2024.
  • BIO-TECHNE's Net Cash Flow's 5-year high stood at $46.1 million during FY2021, with a 5-year trough of -$26.4 million in FY2024.
  • Over the past 3 years, BIO-TECHNE's median Net Cash Flow value was -$1.5 million (recorded in 2025), while the average stood at -$5.5 million.
  • As far as peak fluctuations go, BIO-TECHNE's Net Cash Flow soared by 178.71% in 2023, and later slumped by 332.81% in 2024.
  • BIO-TECHNE's Net Cash Flow (Yearly) stood at $46.1 million in 2021, then slumped by 131.31% to -$14.4 million in 2022, then surged by 178.71% to $11.4 million in 2023, then plummeted by 332.81% to -$26.4 million in 2024, then spiked by 94.21% to -$1.5 million in 2025.